Newsroom

RÓMA--(BUSINESS WIRE)--A Microsoft és a Postel, a Poste Italiane Group vállalata bejelentette együttműködését, illetve az olasz vállalkozások digitalizációja érdekében aláírt megállapodásaik továbbvitelét, technológiai partnerként üdvözölve az Audiencerate-et, az adat- és direkt, valamint digitális marketing területén. A megállapodás egy integrált platform létrehozását célozza meg, amely a Postel többcsatornás („omnichannel") fizikai és digitális kommunikációs képességeit az Audiencerate adatel...

HOUSTON--(BUSINESS WIRE)--NRG Energy, Inc. (NYSE:NRG) announced today the early results of the previously announced offer to purchase for cash (the “Tender Offer”) for any and all of the outstanding 7.250% senior secured notes due 2032 (the “Notes”) issued by Lightning Power, LLC (“Lightning”), a wholly-owned subsidiary of NRG. In conjunction with the Tender Offer, Lightning also solicited consents (the “Consent Solicitation”) to adopt certain proposed amendments to the indenture governing the...

CANTON, Mass.--(BUSINESS WIRE)--MEDITECH announced today that Vice Chair and former CEO Howard Messing has been appointed Chair of the company's Board of Directors....

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, has nominated Kofi Amoo-Gottfried for election as a new director at the company’s 2026 annual shareholder meeting in June. Amoo-Gottfried is a seasoned marketing leader with decades of experience helping global transformative brands change how consumers think about their everyday lives. He served as Chief Marketing Officer at DoorDash and in leadership roles at...

LOS ANGELES--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced a new partnership with Olympia Pharmaceuticals, a state-of-the-art U.S. FDA-registered 503B outsourcing facility, to compound and distribute pharmaceutical-grade Niagen® (patented nicotinamide riboside, NR) for the Company’s Niagen Plus™ intravenous and injectable products. Olympia Pharmaceuticals joi...

HOUSTON--(BUSINESS WIRE)--Cheniere Partners Declares Quarterly Distributions...

VALLEY FORGE, Pa. & NEW YORK--(BUSINESS WIRE)--UGI Utilities, Inc. (UGI Utilities), a wholly owned subsidiary of UGI Corporation (NYSE: UGI), today announced a definitive agreement to sell its Electric Division to funds managed by Argo Infrastructure Partners LP (Argo), a well-established mid-market manager of essential infrastructure and utility assets. The purchase price is approximately $470 million with working capital adjustments. After-tax proceeds will be used to reduce UGI debt and for...

SANTA CLARA, Calif.--(BUSINESS WIRE)--OpenLight, the world leader in custom Photonic Application-Specific Integrated Circuit (PASIC) design leveraging its patented heterogeneous silicon photonics process, today announced it has raised an additional $50 million in a Series A-1 round, bringing the company’s total funding to $84 million. The financing reflects growing commercial momentum and accelerating customer adoption across AI infrastructure, automotive and industrial sensing, medical and qua...

AUSTIN, Texas--(BUSINESS WIRE)--Ambiq Micro, Inc. (NYSE: AMBQ), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced that it will report its first quarter 2026 financial results on Tuesday, May 12, 2026 before the market opens. The Company will host a conference call at 7:30 a.m. Central Time (8:30 a.m. Eastern Time) to discuss the results. Analysts and investors are invited to join the live conference call using the following information: Date: Tuesday, M...

HOUSTON--(BUSINESS WIRE)--Cheniere Declares Quarterly Dividend...